Not Medicare Enrolled

Dr. Dhiren Patel, DO

Addiction Medicine (Psychiatry & Neurology) Physician · Dallas, TX
Low-engagement
1475 PRUDENTIAL DR, Dallas, TX 75235
2145224640
In practice since 2006 (19 years)
NPI: 1528078466 verify on NPPES ↗
Moderate
DATA COVERAGE
Data in 2 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Patel from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Patel? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Patel

Dr. Dhiren Patel is an addiction medicine (psychiatry & neurology) physician in Dallas, TX, with 19 years in practice.

Between the years covered by Open Payments, Dr. Patel received a total of $25,146 from 49 pharmaceutical and/or device companies across 1008 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in addiction medicine (psychiatry & neurology) physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Patel is Moderate — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice$ $25,146 industry payments

Industry Payment Transparency

Open Payments through 2024 ↗
$25,146
Total received (2018-2024)
Avg $3,592/year across 7 years
Top 21% in TX for addiction medicine (psychiatry & neurology) physician
49
Companies
1,008
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$15,835 (63.0%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$9,311 (37.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$4,132
2023
$3,089
2022
$1,612
2021
$2,086
2020
$1,295
2019
$5,499
2018
$7,433

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Janssen Pharmaceuticals, Inc
$4,346
US WorldMeds, LLC
$4,019
Otsuka America Pharmaceutical, Inc.
$2,674
Neuronetics, Inc.
$1,883
Takeda Pharmaceuticals U.S.A., Inc.
$1,305
Lundbeck LLC
$1,193
Indivior Inc.
$909
Tris Pharma Inc
$882
Sunovion Pharmaceuticals Inc.
$801
ABBVIE INC.
$639
Almatica Pharma LLC
$436
Corium, LLC
$401
Teva Pharmaceuticals USA, Inc.
$372
Ironshore Pharmaceuticals Inc.
$366
Bausch Health US, LLC
$361
AbbVie Inc.
$356
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$344
ITI, Inc.
$342
Supernus Pharmaceuticals, Inc.
$321
Orexo US, Inc.
$273
Allergan Inc.
$273
Neos Therapeutics, LP
$224
Neurocrine Biosciences, Inc.
$223
Shire North American Group Inc
$223
IDORSIA PHARMACEUTICALS US INC
$213
Eisai Inc.
$188
Alkermes, Inc.
$178
Braeburn Inc.
$172
Axsome Therapeutics, Inc.
$159
Noven Therapeutics, LLC
$139
Vanda Pharmaceuticals Inc.
$129
Allergan, Inc.
$117
Avanir Pharmaceuticals, Inc.
$103
Vertical Pharmaceuticals, LLC
$98
ARBOR PHARMACEUTICALS, INC.
$64
OWP Pharmaceuticals, Inc.
$47
Merck Sharp & Dohme LLC
$44
IRONSHORE PHARMACEUTICALS INC.
$40
Pear Therapeutics (US), Inc.
$40
JAZZ PHARMACEUTICALS INC.
$38
Adlon Therapeutics L.P.
$35
Tempus AI, Inc
$34
EISAI INC.
$34
Merck Sharp & Dohme Corporation
$22
Hikma Pharmaceuticals USA
$21
Biogen, Inc.
$20
E.R. Squibb & Sons, L.L.C.
$16
USWM, LLC
$14
Amgen Inc.
$14
Top 3 companies account for 43.9% of total payments
Associated products mentioned in payments ›
ABILIFY MAINTENA · ABILIFY MYCITE · ADHANSIA XR · APLENZIN · ARISTADA · AUSTEDO · AZSTARYS · Adzenys XR-ODT · Aimovig · Austedo XR · Auvelity · Azstarys · BELSOMRA · BRINTELLIX · BRIXADI · CAPLYTA · COBENFY · Dayvigo · Dyanavel XR · Evekeo · FANAPT · Fanapt · Fycompa · GRALISE · HETLIOZ · INGREZZA · INVEGA SUSTENNA · INVEGA TRINZA · JORNAY PM · Jornay PM 20mg capsules (Bottle of 100) · Kloxxado · LATUDA · LOREEV XR · Lamotrigine Starter Kit · Lucemyra · Lucemyra/Lofexidine · METHYLPHENIDATE 72 · MYDAYIS · NEUROSTAR TMS THERAPY · NUEDEXTA · QELBREE · QUVIVIQ · Qelbree · Quillichew ER · Quillivant · RELEXXII · REXULTI · Relexxii · SPINRAZA · SPRAVATO · SUBLOCADE · SUBOXONE SUBLINGUAL FILM · SUNOSI · Secuado · Subvenite · TRINTELLIX · Trintellix · UBRELVY · UZEDY · VIVITROL · VRAYLAR · VYVANSE · Vivitrol · WELLBUTRIN · WELLBUTRIN XL · Zubsolv · reSET-O
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (63%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a addiction medicine (psychiatry & neurology) physician in Dallas?
Compare addiction medicine (psychiatry & neurology) physicians in the Dallas area by procedure volume, costs, and industry payment transparency.
Browse addiction medicine (psychiatry & neurology) physicians nearby

Geographic Context

Addiction Medicine (Psychiatry & Neurology) Physicians within 10 mi
7
Per 100K population
0.3
County median income
$74,149
Nearest hospital
PARKLAND HEALTH & HOSPITAL SYSTEM
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment— Not enrolledN/A
Practice Data— No dataN/A
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 2 of 4 available federal datasets, with a Data Coverage level of Moderate. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Patel is a addiction medicine (psychiatry & neurology) physician, and low-engagement industry engagement, with 19 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Does Dr. Patel receive payments from pharmaceutical companies?
Yes. Dr. Patel received a total of $25,146 from 49 companies across 1,008 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently Moderate for Dr. Patel) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →